Novo Holdings
Investor profile | Builders Republic
About
Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations. Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S and manages an investment portfolio, with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, Principal and Planetary Health Investments teams, Novo Holdings invests in life science companies at all stages of development.
Key facts
- Type
- Corporate VC
- Stages
- Seed,Series A,Series B,Growth,Buyout
- Sectors
- Healthcare,Life sciences
- Headquarters
- Denmark
- Offices
- Hellerup,Copenhagen,London,San Francisco,Boston,Singapore,Shanghai
- Geographic focus
- Europe,France
- Lead / Follow
- Lead / co-lead
- Ticket size
- 1M€ – 500M€
- Assets under management
- 142000M€
- Founded
- 1999
Track record
- Portfolio companies: 181
- Total investments: 306
- Exits: 262
Notable investments in France
Coave Therapeutics, Corwave
Key differentiators
Multi-Assets Fund,Sector Specialist,Global Footprint